634 related articles for article (PubMed ID: 22829562)
1. Cardiometabolic aspects of the polycystic ovary syndrome.
Randeva HS; Tan BK; Weickert MO; Lois K; Nestler JE; Sattar N; Lehnert H
Endocr Rev; 2012 Oct; 33(5):812-41. PubMed ID: 22829562
[TBL] [Abstract][Full Text] [Related]
2. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
Dimitriadis GK; Kyrou I; Randeva HS
Curr Pharm Des; 2016; 22(36):5535-5546. PubMed ID: 27464726
[TBL] [Abstract][Full Text] [Related]
3. New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.
Ravn P
Minerva Ginecol; 2015 Apr; 67(2):217-23. PubMed ID: 25668421
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
5. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.
Escobar-Morreale HF; Samino S; Insenser M; Vinaixa M; Luque-Ramírez M; Lasunción MA; Correig X
Clin Chem; 2012 Jun; 58(6):999-1009. PubMed ID: 22427353
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.
Anagnostis P; Tarlatzis BC; Kauffman RP
Metabolism; 2018 Sep; 86():33-43. PubMed ID: 29024702
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and the metabolic syndrome.
Weerakiet S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
Spritzer PM; Lecke SB; Satler F; Morsch DM
Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
10. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
[TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
12. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
13. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
Baldani DP; Skrgatic L; Ougouag R; Kasum M
Gynecol Endocrinol; 2018 Feb; 34(2):87-91. PubMed ID: 28944709
[TBL] [Abstract][Full Text] [Related]
14. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
Kakoly NS; Moran LJ; Teede HJ; Joham AE
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome.
Oróstica L; Astorga I; Plaza-Parrochia F; Vera C; García V; Carvajal R; Gabler F; Romero C; Vega M
Int J Obes (Lond); 2016 Nov; 40(11):1715-1722. PubMed ID: 27569685
[TBL] [Abstract][Full Text] [Related]
18. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
19. The role of obesity in the development of polycystic ovary syndrome.
Motta AB
Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
[TBL] [Abstract][Full Text] [Related]
20. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
